<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Research | Eanna Kenny</title>
<link rel="icon" type="image/svg+xml" href="favicon.svg">
<link rel="preconnect" href="https://fonts.googleapis.com">
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600&family=Inter:wght@300;400;500&display=swap" rel="stylesheet">
<script src="https://cdn.tailwindcss.com"></script>
<style>
body { font-family: 'Inter', sans-serif; }
h1, h2, h3 { font-family: 'Cormorant Garamond', serif; }
.section { margin-bottom: 3rem; }
</style>
</head>

<body class="bg-white text-slate-800">

<nav class="max-w-6xl mx-auto py-6 flex justify-between text-sm">
  <div class="font-semibold">Eanna Kenny, PhD</div>
  <a href="index.html">Home</a>
</nav>

<section class="max-w-4xl mx-auto py-20">

<h1 class="text-4xl mb-12">Research Programme</h1>

<div class="section">
<h2 class="text-2xl mb-4">Optimising Digital Cardiac Rehabilitation</h2>
<p class="text-slate-600">
My doctoral research applied the Multiphase Optimisation Strategy (MOST) 
to enhance digitally delivered cardiac rehabilitation. This programme 
included a systematic review and meta-analysis, a qualitative exploration of 
patient experiences, development of a theoretically informed conceptual model, and a 2x2x2 factorial feasibility trial of a digital cardiac rehabilitation intervention.
</p>
</div>

<div class="section">
<h2 class="text-2xl mb-4">Multimorbidity & Primary Care (MIDAS Trial)</h2>
<p class="text-slate-600">
As a Postdoctoral Researcher at Trinity College Dublin, I contribute to 
the delivery and evaluation of a multi-site cluster randomised trial 
addressing patient priorities in multimorbidity across 48 general practices. 
My role is focuses on managing the one arm of the trial and leading the process evaluation.
</p>
</div>

<div class="section">
<h2 class="text-2xl mb-4">International Cardiovascular Risk Research</h2>
<p class="text-slate-600">
Through collaboration with the National Institute for Prevention and 
Cardiovascular Health, I have contributed to international research 
examining patient and physician perspectives on lipoprotein(a) testing and cardiovascular risk management 
across seven countries. My role has involved questionnaire development and validation.
</p>
</div>

</section>

</body>
</html>
